BeStock  
Stocks › Biotechnology › ATTO

Attovia Therapeutics ATTO

US equityMarket cap rank #3395Biotechnology
$15.10 −$0.48 (-3.08%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $15.10 0.00%
Open$15.40
Prev close$15.58
Day range$14.80 – $15.46
Volume372.2K
Market cap$690.26M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-8.8x
CheapRich

Near the top of its 5-year range · 94th percentile, 5-year average -11.3x

Price / book1.7x
CheapRich

Near the top of its 5-year range · 96th percentile, 5-year average -5.3x

#2784 of 5329 stocks by PB (1 = cheapest)

Price / sales480.3x
CheapRich

Around its usual level · 56th percentile, 5-year average 478.6x

#5058 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-18x-11x-5x1xJul '26Sep '26Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$18.31
Price vs. fair value-17.5%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 1.74 – -5.27 96% (pricier than usual) #2784 of 5329 (1 = cheapest)
PE -8.76 -7.14 -11.32 94% (pricier than usual) –
PS 480.30 – 478.64 56% (pricier than usual) #5058 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on ATTO.

Sign in to join the discussion.

Scroll to Top